http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023
-
AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference
-
AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award
-
AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference
-
AtriCure Reports Third Quarter 2022 Financial Results
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Announce Third Quarter 2022 Financial Results
-
AtriCure Announces Investor Education Webcast with Hybrid AF Therapy Key Opinion Leaders
-
AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
-
AtriCure Reports Second Quarter 2022 Financial Results
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure to Announce Second Quarter 2022 Financial Results
-
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
-
AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
-
AtriCure Reports First Quarter 2022 Financial Results
-
AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System
-
AtriCure to Announce First Quarter 2022 Financial Results
-
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
-
AtriCure Publishes Inaugural ESG Report
-
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
-
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
-
AtriCure (ATRC) Prelim. Q4 Revenue Tops Consensus
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
-
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
-
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
-
AtriCure Reports Third Quarter 2021 Financial Results
-
AtriCure to Participate in Upcoming Investor Conferences
-
AtriCure to Announce Third Quarter 2021 Financial Results
-
AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
-
AtriCure Reports Second Quarter 2021 Financial Results
-
AtriCure to Participate at the Canaccord 41st Annual Growth Conference
-
AtriCure to Announce Second Quarter 2021 Financial Results
-
AtriCure Names Two New Members to the Board of Directors
-
AtriCure (ATRC) EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
-
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
-
AtriCure Reports First Quarter 2021 Financial Results
-
AtriCure Names B. Kristine Johnson Board Chair
-
AtriCure to Announce First Quarter 2021 Financial Results
-
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference
-
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
-
AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference
-
AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
-
AtriCure (ATRC) Reports Preliminary Results for Fourth Quarter and Full Year 2020
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
-
AtriCure (ATRC) Announces Labeling Expansion for Cryo Nerve Block Therapy
-
AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy
-
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
-
AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
-
AtriCure Reports Third Quarter 2020 Financial Results
-
AtriCure to Participate in Upcoming Investor Conferences

